| 0 |
TICK-BORNE FEVER |
1 |
0.0149 |
| 1 |
TOOTH HYPOPLASIA |
1 |
0.0057 |
| 2 |
ENAMEL ANOMALY |
1 |
0.0035 |
| 3 |
LYMPHOID TISSUE HYPERPLASIA |
1 |
0.0028 |
| 4 |
BIPOLAR II DISORDER |
1 |
0.0028 |
| 5 |
PSEUDOPOLYP |
1 |
0.0028 |
| 6 |
LYMPHOCYTE PERCENTAGE INCREASED |
1 |
0.0025 |
| 7 |
UTERINE MASS |
1 |
0.0024 |
| 8 |
RENAL ISCHAEMIA |
1 |
0.0018 |
| 9 |
LIP ERYTHEMA |
1 |
0.0013 |
| 10 |
PSYCHOTIC BEHAVIOUR |
1 |
0.0010 |
| 11 |
BLOOD CREATININE ABNORMAL |
3 |
0.0009 |
| 12 |
PRODUCT CONTAMINATION MICROBIAL |
1 |
0.0008 |
| 13 |
POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME |
1 |
0.0007 |
| 14 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
1 |
0.0007 |
| 15 |
PRECANCEROUS CELLS PRESENT |
1 |
0.0007 |
| 16 |
MEGACOLON |
1 |
0.0006 |
| 17 |
LIVING IN RESIDENTIAL INSTITUTION |
1 |
0.0005 |
| 18 |
HERPES VIRUS INFECTION |
3 |
0.0005 |
| 19 |
ISCHAEMIA |
2 |
0.0004 |
| 20 |
URINARY HESITATION |
1 |
0.0004 |
| 21 |
BLOOD CHLORIDE DECREASED |
1 |
0.0004 |
| 22 |
MUCORMYCOSIS |
1 |
0.0004 |
| 23 |
ELECTROCARDIOGRAM ABNORMAL |
3 |
0.0004 |
| 24 |
CHEILITIS |
2 |
0.0004 |
| 25 |
APPLICATION SITE HAEMORRHAGE |
1 |
0.0004 |
| 26 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
1 |
0.0004 |
| 27 |
PROCTITIS |
1 |
0.0004 |
| 28 |
LIP PAIN |
1 |
0.0003 |
| 29 |
PHARYNGEAL DISORDER |
1 |
0.0003 |
| 30 |
NEPHROPATHY |
3 |
0.0003 |
| 31 |
LYME DISEASE |
1 |
0.0003 |
| 32 |
VENTRICULAR EXTRASYSTOLES |
3 |
0.0003 |
| 33 |
CHRONIC GRAFT VERSUS HOST DISEASE |
1 |
0.0003 |
| 34 |
WOUND HAEMORRHAGE |
1 |
0.0003 |
| 35 |
INTRACRANIAL ANEURYSM |
1 |
0.0002 |
| 36 |
APPLICATION SITE EXFOLIATION |
1 |
0.0002 |
| 37 |
CHAPPED LIPS |
1 |
0.0002 |
| 38 |
LIP DRY |
2 |
0.0002 |
| 39 |
NEPHROGENIC ANAEMIA |
1 |
0.0002 |
| 40 |
ORAL HERPES |
4 |
0.0002 |
| 41 |
RENAL TUBULAR NECROSIS |
2 |
0.0002 |
| 42 |
ANEURYSM |
1 |
0.0002 |
| 43 |
AMMONIA INCREASED |
1 |
0.0002 |
| 44 |
DERMATITIS CONTACT |
2 |
0.0002 |
| 45 |
LIVER INJURY |
4 |
0.0002 |
| 46 |
ILEUS |
2 |
0.0002 |
| 47 |
HERPES SIMPLEX |
1 |
0.0002 |
| 48 |
CROHN'S DISEASE |
1 |
0.0001 |
| 49 |
DROOLING |
1 |
0.0001 |
| 50 |
EATING DISORDER |
3 |
0.0001 |
| 51 |
RED BLOOD CELL COUNT DECREASED |
4 |
0.0001 |
| 52 |
BRONCHOPULMONARY ASPERGILLOSIS |
1 |
0.0001 |
| 53 |
BLOOD MAGNESIUM DECREASED |
1 |
0.0001 |
| 54 |
RASH MACULAR |
4 |
0.0001 |
| 55 |
PNEUMONITIS |
3 |
0.0001 |
| 56 |
HEPATIC ENCEPHALOPATHY |
1 |
0.0001 |
| 57 |
APPENDICITIS |
1 |
0.0001 |
| 58 |
INFLAMMATORY BOWEL DISEASE |
1 |
0.0001 |
| 59 |
INITIAL INSOMNIA |
1 |
0.0001 |
| 60 |
MOVEMENT DISORDER |
3 |
0.0001 |
| 61 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
2 |
0.0001 |
| 62 |
SKIN LACERATION |
1 |
0.0001 |
| 63 |
OESOPHAGITIS |
1 |
0.0001 |
| 64 |
ASPIRATION |
1 |
0.0001 |
| 65 |
LIP SWELLING |
3 |
0.0001 |
| 66 |
ORAL PAIN |
2 |
0.0001 |
| 67 |
BLOOD CALCIUM DECREASED |
1 |
0.0001 |
| 68 |
CARDIOMEGALY |
1 |
0.0001 |
| 69 |
APPLICATION SITE ERYTHEMA |
2 |
0.0001 |
| 70 |
APPLICATION SITE RASH |
1 |
0.0001 |
| 71 |
ORAL DISCOMFORT |
1 |
0.0001 |
| 72 |
APHONIA |
1 |
0.0001 |
| 73 |
THYROID DISORDER |
1 |
0.0001 |
| 74 |
BRAIN FOG |
1 |
0.0001 |
| 75 |
SCAR |
1 |
0.0001 |
| 76 |
MULTI-ORGAN FAILURE |
1 |
0.0001 |
| 77 |
END STAGE RENAL DISEASE |
1 |
0.0001 |
| 78 |
AGRANULOCYTOSIS |
1 |
0.0001 |
| 79 |
MIDDLE INSOMNIA |
1 |
0.0001 |
| 80 |
TUBULOINTERSTITIAL NEPHRITIS |
1 |
0.0001 |
| 81 |
HAEMORRHOIDS |
1 |
0.0001 |
| 82 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 83 |
IRRITABLE BOWEL SYNDROME |
1 |
0.0000 |
| 84 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
1 |
0.0000 |
| 85 |
LIVER DISORDER |
2 |
0.0000 |
| 86 |
TOOTH DISORDER |
1 |
0.0000 |
| 87 |
PANCREATITIS ACUTE |
1 |
0.0000 |
| 88 |
LOCALISED INFECTION |
1 |
0.0000 |
| 89 |
PRODUCT COMPLAINT |
1 |
0.0000 |
| 90 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 91 |
RASH GENERALISED |
1 |
0.0000 |
| 92 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 93 |
GASTRITIS |
1 |
0.0000 |
| 94 |
WHITE BLOOD CELL COUNT DECREASED |
4 |
0.0000 |
| 95 |
SKIN LESION |
1 |
0.0000 |
| 96 |
RESPIRATORY DISTRESS |
1 |
0.0000 |
| 97 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 98 |
PANCYTOPENIA |
2 |
0.0000 |
| 99 |
INCORRECT DRUG ADMINISTRATION DURATION |
1 |
0.0000 |
| 100 |
RENAL INJURY |
1 |
0.0000 |
| 101 |
GASTROINTESTINAL DISORDER |
3 |
0.0000 |
| 102 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 103 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
6 |
0.0000 |
| 104 |
ILL-DEFINED DISORDER |
2 |
0.0000 |
| 105 |
DRUG INTOLERANCE |
3 |
0.0000 |
| 106 |
NIGHT SWEATS |
1 |
0.0000 |
| 107 |
URINARY RETENTION |
1 |
0.0000 |
| 108 |
GASTRIC DISORDER |
1 |
0.0000 |
| 109 |
DYSURIA |
1 |
0.0000 |
| 110 |
SEPSIS |
3 |
0.0000 |
| 111 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 112 |
COLITIS |
1 |
0.0000 |
| 113 |
CHRONIC KIDNEY DISEASE |
2 |
0.0000 |
| 114 |
CARDIAC FAILURE CONGESTIVE |
2 |
0.0000 |
| 115 |
NEUTROPHIL COUNT DECREASED |
1 |
0.0000 |
| 116 |
ERYTHEMA |
5 |
0.0000 |
| 117 |
RENAL FAILURE |
3 |
0.0000 |
| 118 |
COLITIS ULCERATIVE |
1 |
0.0000 |
| 119 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 120 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 121 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 122 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 123 |
MULTIPLE SCLEROSIS |
1 |
0.0000 |
| 124 |
ATRIAL FIBRILLATION |
2 |
0.0000 |
| 125 |
SPEECH DISORDER |
1 |
0.0000 |
| 126 |
OEDEMA |
1 |
0.0000 |
| 127 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 128 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 129 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 130 |
NASOPHARYNGITIS |
3 |
0.0000 |
| 131 |
SWELLING FACE |
1 |
0.0000 |
| 132 |
ALOPECIA |
3 |
0.0000 |
| 133 |
NEOPLASM MALIGNANT |
1 |
0.0000 |
| 134 |
NEUTROPENIA |
2 |
0.0000 |
| 135 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 136 |
WEIGHT DECREASED |
4 |
0.0000 |
| 137 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 138 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 139 |
WEIGHT INCREASED |
3 |
0.0000 |
| 140 |
EPISTAXIS |
1 |
0.0000 |
| 141 |
ACUTE KIDNEY INJURY |
2 |
0.0000 |
| 142 |
FEELING ABNORMAL |
3 |
0.0000 |
| 143 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 144 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 145 |
ABDOMINAL DISCOMFORT |
2 |
0.0000 |
| 146 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 147 |
URINARY TRACT INFECTION |
2 |
0.0000 |
| 148 |
MALAISE |
5 |
0.0000 |
| 149 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 150 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 151 |
VOMITING |
5 |
0.0000 |
| 152 |
DYSPHAGIA |
1 |
0.0000 |
| 153 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
2 |
0.0000 |
| 154 |
MALIGNANT NEOPLASM PROGRESSION |
1 |
0.0000 |
| 155 |
CONSTIPATION |
2 |
0.0000 |
| 156 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 157 |
CHILLS |
1 |
0.0000 |
| 158 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 159 |
DRUG INEFFECTIVE |
10 |
0.0000 |
| 160 |
DEHYDRATION |
1 |
0.0000 |
| 161 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 162 |
HYPOAESTHESIA |
1 |
0.0000 |
| 163 |
CONDITION AGGRAVATED |
2 |
0.0000 |
| 164 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 165 |
PAIN |
4 |
0.0000 |
| 166 |
DRUG DEPENDENCE |
1 |
0.0000 |
| 167 |
URTICARIA |
1 |
0.0000 |
| 168 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 169 |
MUSCLE SPASMS |
1 |
0.0000 |
| 170 |
CHEST PAIN |
1 |
0.0000 |
| 171 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 172 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 173 |
PRURITUS |
2 |
0.0000 |
| 174 |
NAUSEA |
4 |
0.0000 |
| 175 |
HYPOTENSION |
1 |
0.0000 |
| 176 |
SOMNOLENCE |
1 |
0.0000 |
| 177 |
DEPRESSION |
1 |
0.0000 |
| 178 |
DECREASED APPETITE |
1 |
0.0000 |
| 179 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 180 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 181 |
INSOMNIA |
1 |
0.0000 |
| 182 |
ANXIETY |
1 |
0.0000 |
| 183 |
PYREXIA |
1 |
0.0000 |
| 184 |
ASTHENIA |
1 |
0.0000 |
| 185 |
RASH |
1 |
0.0000 |
| 186 |
DIZZINESS |
1 |
0.0000 |
| 187 |
DIARRHOEA |
1 |
0.0000 |
| 188 |
FATIGUE |
1 |
0.0000 |
| 189 |
OFF LABEL USE |
1 |
0.0000 |